The British journal of dermatology
-
Randomized Controlled Trial Multicenter Study
Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis.
Psoriasis affects patients both physically and psychologically. ⋯ Disease severity, depression and PsA were significant predictors of poor HRQoL. Infliximab significantly improved HRQoL, regardless of these characteristics.